Preferred Citation: Jamner, Margaret Schneider, and Daniel Stokols, editors. Promoting Human Wellness: New Frontiers for Research, Practice, and Policy. Berkeley:  University of California Press,  c2000 2000. http://ark.cdlib.org/ark:/13030/kt4r29q2tg/


 
RACE AND HEALTH

REFERENCES

1. The Random House College Dictionary. Revised ed. 1975. New York: Random House.

2. Roach, M., Alexander, M., and Coleman, J.1992. “The prognostic significance of race on survival from laryngeal carcinoma.” Journal of the National Medical Association84, 668–674.

3. Jones, James H.1981. Bad Blood: The Tuskegee Syphilis Experiment.New York: The Free Press, 34.

4. Nortzon, F. C., Komarov, Y. M., Ermakov, S. P., et al. 1998. “Causes of declining life expectancy in Russia.” Journal of the American Medical Association279, 793–800.

5. “National Cancer Institute.” 1993. SEER cancer statistics review: 1973–1990. In NIH Publication 93-2789. Bethesda, Md.: National Cancer Institute.

6. Jones, James H.1981. Bad Blood: The Tuskegee Syphilis Experiment, New York: The Free Press, 38.

7. Moul, J. W., Douglas, T. H., McCarthy, W. F., and McLeod, D. G.1996. “Black race is an adverse prognostic factor for prostate cancer recurrence following radical prostatectomy in an equal access health care setting.” Journal of Urology155, 1667–1673.

8. Bauer, J. J., Connelly, R. R., Sesterhenn, I. A., et al. 1997. “Biostatistical modeling using traditional variables and genetic biomarkers for predicting the risk of prostate carcinoma recurrence after radical prostatectomy.” Cancer79, 952–962.

9. Gould, Stephen J.1996. The Mismeasure of Man. 2nd ed. New York: W. W. Norton.

10. Franklin, J. H., and Moss, A. A.1994. From Slavery to Freedom: A History of African Americans. 7th ed. New York: McGraw-Hill, 41.

11. Curtin, P. D.1969. The Atlantic Slave Trade: A Census.Pp. 275–276. Madison: University of Wisconsin Press.

12. Harley, S.1995. “The timetables of African-American history.” In S. Harley, ed., A Chronology of the Most Important People and Events in African-American History.Pp. 226–275. New York: Simon and Schuster.

13. Satariano, W. A., Belle, S. H., and Swanson, G. M.1986. “The severity of breast cancer at diagnosis: A comparison of age and extent of disease in black and white women.” American Journal of Public Health76, 779–782.

14. Bassett, M. T., and Krieger, N. K.1986. “Social class and black-white differences in breast cancer survival.” American Journal of Public Health76, 1400–1403.

15. Austin, J.-P., Covery, K., and Rotman, M.1990. “Age-race interaction in prostate adenocarcinoma treated with external irradiation.” International Journal of Radiation Oncology Biology Physics19 (Suppl. 1), 200.


289

16. Dayal, H., Power, R., and Chui, C.1982. “Race and socio-economic status in survival from breast cancer.” Journal of Chronic Diseases27, 675–683.

17. Ernster, V. L., Selvin, S., Sacks, S. T., et al. 1978. “Prostatic cancer: Mortality and incidence rates by race and social class.” American Journal of Epidemiology107, 311–320.

18. Keirn, W., and Meter, G.1985. “Survival of cancer patients by economic status in a free care setting.” Cancer55, 1552–1555.

19. Page, W. F., and Kuntz, A. J.1980. “Racial and socioeconomic factors in cancer survival.” Cancer45, 1029–1040.

20. Ruffer, J. E., Barry, E. E., Terry, P., et al. 1991. “Lower radiation dose may account for decreased survival of blacks with prostate cancer: Results of the 1978 patterns of care study.” International Journal of Radiation Oncology Biology Physics21 (1), 212.

21. Diehr, P., Yergan, J., Chu, J., et al. 1989. “Treatment modality and quality differences for black and white breast cancer patients treated in community hospitals.” Medical Care27, 942–958.

22. Egbert, L. D., and Rothman, I. L.1977. “Relationship between race and economic status of patients and who performs their surgery.” New England Journal of Medicine297, 90–91.

23. Flaherty, J. A., and Meagher, R.1980. “Measuring racial bias in inpatient treatment.” American Journal of Psychiatry137, 679–682.

24. McWhorter, W. P., and Mayer, W. J.1987. “Black-white differences in type of initial breast cancer treatment and implications for survival.” American Journal of Public Health77, 1515–1517.

25. National Institutes of Health.1994. National Institutes of Health Guide for Grants and Contracts23 (11, March 18), 2.

26. Roach, M., and Alexander, M.1995. “The prognostic significance of race and survival from breast cancer.” Journal of the National Medical Association87, 214–219.

27. 1997. AJCC Cancer Staging Manual. 5th ed. New York: Lippincott-Raven.

28. Rosen, P. P., Groshen, S., Saigo, P. E., et al. 1989. “A long term follow-up study of survival in stage I (T1N0M0) and stage II (T1N1M0) breast carcinoma.” International Journal of Radiation Oncology Biology Physics7, 355–366.

29. Albain, K. S., Crowley, J. J., LeBlanc, M., et al. 1991. “Survival determinants in extensive-stage non-small-cell lung cancer: The Southwest Oncology Group experience.” Journal of Clinical Oncology9, 1618–1626.

30. Mountain, C. F.1986. “A new international staging system for lung cancer.” Chest89, 225S-233S.

31. Mittra, N. K., Rush, B. F., and Verner, E.1980. “A comparative study of breast cancer in the black and white populations of two inner-city hospitals.” Journal of Surgical Oncology15, 11–17.

32. Gregorio, D. I., Cummings, K. M., and Michalek, A.1983. “Delay, stage of disease, and survival among white and black women with breast cancer.” American Journal of Public Health73, 590–593.

33. Valanis, B., Wirman, J., and Hertzberg, V. S.1987. “Social and biological factors in relation to survival among black vs.” white women with breast cancer. Breast Cancer Research and Treatment9, 134–144.


290

34. Polednak, A. P.1988. “A comparison of survival of black and white female breast cancer cases in upstate New York.” Cancer Detection and Prevention11, 245–249.

35. Dansy, R. D., Hessel, P. A., Browde, S., et al. 1988. “Lack of a significant independent effect of race on survival in breast cancer.” Cancer61, 1908–1912.

36. Sutherland, C. M., and Mather, F. J.1988. “Charity hospital experience with long-term survival and prognostic factors in patients with breast cancer with localized or regional disease.” Annals of Surgery207, 569–580.

37. Fields, J. N., Kuske, R. R., Perez, C. A., et al. 1989. “Prognostic factors in inflammatory breast cancer.” Cancer63, 1232–1255.

38. Cella, D. F., Orav, E. J., Kornblith, A. B., et al. 1991. “Socioeconomic status and cancer survival.” Journal of Clinical Oncology9, 1500–1509.

39. Axtell, L. M., and Myers, M. H.1978. “Contrasts in survival of black and white cancer patients, 1960–1973.” Journal of the National Cancer Institute60, 1209–1215.

40. Farrow, D. C., and Hunt, S. J. M.1992. “Geographic variation in the treatment of localized breast cancer.” New England Journal of Medicine326, 1097–1101.

41. Albain, K. S., Green, S., LeBlanc, M., et al. 1992. “Proportional hazards and recursive partitioning and amalgamation analyses of Southwest Oncology node-positive adjuvant CMFVP breast cancer data base: A pilot study.” Breast Cancer Research and Treatment22, 273–284.

42. Roach, M., III, Cirrincione, C., Budman, D., et al. 1997. “Race and Survival from Breast Cancer: Based on Cancer and Leukemia Group B Trial 8541.” The Cancer Journal of Scientific American3, 107–112.

43. Dignam, J. J., Redmond, C., Fisher, B., et al. 1997. “Prognosis among African-American women and white women with lymph node negative breast carcinoma: Findings from two randomized and clinical trials of the National Surgical Adjuvant Breast and Bowel Project (NSABP).” Cancer80 (1), 80–90.

44. Krieger, N.1989. “Exposure, susceptibility, and breast cancer risk.” Breast Cancer and Treatment13, 205–223.

45. Morabia, A., and Wynder, E. L.1990. “Epidemiology and natural history of breast cancer.” Surgical Clinics of North America70, 739–752.

46. Eley, J. W., Hill, H. A., Chen, V. W., et al. 1994. “Racial differences in survival from breast cancer: Results of the National Cancer Institute Black/White Cancer Survival Study.” Journal of the American Medical Association272, 947–954.

47. Nattinger, A. B., Gottlieb, M. S., Verum, B. S., et al. 1992. “Geographic variation in the use of breast-conserving treatment for breast cancer.” New England Journal of Medicine326, 1102–1107.

48. Ragaz, J., Jackson, S. M., Plenderleith, I. H., et al. 1993. “Can adjuvant radiotherapy (XRT) improve the overall survival (OS) of breast cancer (BR CA) patients in the presence of adjuvant chemotherapy (CT)?” 10-year analysis of the British Columbia randomized trial. Proceedings of ASCO12, 70.

49. Natarajan, N., Murphy, G. P., and Mettlin, C.1989. “Prostate cancer in blacks: An update from the American College of Surgeons' patterns of care studies.” Journal of Surgical Oncology40, 232–236.


291

50. Perez, C. A., Garcia, D., Simpson, J. R., et al. 1989. “Factors influencing outcome of definitive radiotherapy for localized carcinoma of the prostate.” Radiotherapy and Oncology16, 1–21.

51. Roach, M., III, Krall, J., Keller, J. W., et al. 1992. “The prognostic significance of race and survival from prostate cancer based on patients irradiated on Radiation Therapy Oncology Group protocols (1976–1985).” International Journal of Radiation Oncology Biology Physics24, 441–449.

52. Epstein, J. I., Paull, G., Eggleston, J. C., et al. 1986. “Prognosis of untreated stage A1 prostatic carcinoma: A study of 94 cases with extended followup.” Journal of Urology136, 837–839.

53. Levine, R. L., and Wilchinsky, M.1979. “Adenocarcinoma of the prostate: A comparison of the disease in blacks versus whites.” Journal of Urology121, 761–762.

54. Roach, M., III. “Is race an independent prognostic factor for survival from prostate cancer?” Journal of the National Medical Association90 (11, suppl.).

55. Vijayakumar, S., Winter, K., Sause, W., et al. 1998. “Prostate specific antigen levels are higher in African-American patients than whites in a national registration study: Results of RTOG 94–12.” International Journal of Radiation Oncology Biology Physics40, 17–25.

56. Chamberlain, R., Winter, K., Vijayakumar, S., et al. 1998. “Radiation Therapy Oncology Group demographic analysis of subjects in multicenter clinical trials.” International Journal of Radiation Oncology Biology Physics40, 9–15.

57. Graham, M. V., Geitz, L. M., Byhardt, R., et al. 1992. “Comparison of prognostic factors and survival among black and white patients treated with radiation therapy for non-small cell lung cancer.” Journal of the National Cancer Institute84, 731–735.

58. Simpson, J. R., Scott, C. B., Curran, W. J., et al. 1993. “Race, gender and socioeconomic status of brain tumor patients entering multicenter clinical trials—A report from the Radiation Oncology Group.” International Journal of Radiation Oncology Biology Physics26, 239–244.

59. Streeter, O. E., Martz, K. L., Gaspar, L. E., et al. 1999. “Does race influence survival for esophageal cancer?” An analysis of patients treated with chemoradiation on RTOG 85–01. International Journal of Radiation Oncology Biology Physics44 (5), 1047–1052.

60. Modiano, M. R., Villar-Werstler, P., Crowley, J., et al. 1996. “Evaluation of race as a prognostic factor in multiple myeloma: An ancillary of Southwest Oncology Group Study 8229.” Journal of Clinical Oncology14, 974–977.

61. Pui, C.-H., Boyett, J. M., Hancock, M. L., et al. 1995. “Outcome of treatment for childhood cancer in black as compared with white children: The St. Jude Children's Research Hospital experience, 1962 through 1992.” Journal of the American Medical Association273, 633–637.

62. Gabel, L. L., and Weddington, W. H.1993. “Obligation and opportunity: Family practice research regarding race and quality of care.” Family Practice Research Journal13 (2), 101–104.

63. Weddington, W. H., Gabel, L. L., Peet, G. M., et al. 1992. “Quality of care and black American patients.” Journal of the National Medical Association84 (7), 569–575.


292

64. Gorey, K. M., and Vena, J. E.1994. “Cancer differentials among U.S. blacks and whites: Quantitative estimates of socioeconomic-related risks.” Journal of the National Medical Association86 (3), 209–215.

65. Fang, J., Madhavan, S., and Alderman, M.1996. “The association between birthplace and mortality from cardiovascular causes among black and white residents of New York.” New England Journal of Medicine335 (21), 1545–1551.

66. Krieger, N., and Sidney, S.1996. “Racial discrimination and blood pressure: The CARDIA Study of young black and white adults.” American Journal of Public Health86, 1370–1378.

67. Ayanian, J. Z., Udvarhelyi, S., Gatsonis, C. A., et al. 1993. “Racial differences in the use of revascularization procedures after coronary angiography.” Journal of the American Medical Association269 (20), 2642–2646.

68. Peterson, E., Wright, S. M., Daley, J., and Thibault, G. E.1994. “Racial variation in cardiac procedure use and survival following acute myocardial infarction in the Department of Veterans Affairs.” Journal of the American Medical Association271, 1175–1180.

69. Kahn, K. L., Pearson, M. L., Harrison, E. R., et al. 1994. “Health care for black and poor hospitalized medicare patients.” Journal of the American Medical Association271, 1169–1174.

70. Geronimus, A. T., Bound, J., Waidmann, T. A., et al. 1996. “Excess mortality among blacks and whites in the United States.” New England Journal of Medicine335, 1552–1558.

71. Hafner-Eaton, C.1993. “Physician utilization disparities between the uninsured and insured: Comparisons of the chronically ill, acutely ill and well non-elderly populations.” Journal of the American Medical Association269, 787–792.

72. Worthington, C.1992. “An examination of factors influencing the diagnosis and treatment of black patients in the mental health system.” Archives of Psychiatric Nursing6 (3), 195–204.

73. Hoffman, P.1994. “The science of race.” Discover: The World of Science15 (4, Special Issue), 4.

74. Gould, S. J.1994. “The geometer of race.” Discover: The World of Science15 (4, Special Issue), 64–69.

75. Gutin, J. A.1994. “End of the rainbow.” Discover: The World of Science15 (4, Special Issue), 70–75.

76. Diamond, J.1994. “Race without color.” Discover: The World of Science15 (4, Special Issue), 82–89.

77. Begley, S.1995. “Three is not enough.” Newsweek, February 13, 67–69.

78. Miller, A.1994/1995. “The Pioneer Fund: Bankrolling the professors of hate.” Journal of Blacks in Higher Education, no. 6(winter), 58–61.

79. Rowan, C. T.1996. The Coming Race War in America.Boston: Little, Brown, 17.

80. King, Martin Luther, Jr.1991. “Historic essays: Letter from Birmingham City Jail (written April 16, 1963).” In A Testament of Hope: The Essential Writings and Speeches of Martin Luther King, Jr., edited by James M. Washington. San Francisco: HarperCollins, 294.


293

81. King, Martin Luther, Jr.1991. “Famous sermons and public addresses: Where Do We Go From Here? (written April 1967).” In A Testament of Hope: The Essential Writings and Speeches of Martin Luther King, Jr., edited by James M. Washington. San Francisco: HarperCollins, 251.

82. Morrison, T.1993. Playing in the Dark: Whiteness and the Literary Imagination.New York: Vintage Books.

83. Brown, B., trans.1995. The Tao Te Ching of Lao Tzu.New York: St. Martin's Press, Saying 27.


RACE AND HEALTH
 

Preferred Citation: Jamner, Margaret Schneider, and Daniel Stokols, editors. Promoting Human Wellness: New Frontiers for Research, Practice, and Policy. Berkeley:  University of California Press,  c2000 2000. http://ark.cdlib.org/ark:/13030/kt4r29q2tg/